Ozempic Ad - Search News

Novo Nordisk’s Ozempic Gets FDA Approval

Ozempic approved for chronic kidney disease patients

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Another busy

People on MSN · 1d

FDA Approves Ozempic to Treat Kidney Disease

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease.

kffhealthnews · 1d

Ozempic Approved To Treat Chronic Kidney Disease With Type 2 Diabetes

The FDA's move may change how doctors treat chronic kidney disease, which, according to Ozempic maker Novo Nordisk, affects around 37 million Americans and is one of the leading causes of death in the United States.

2d

Ozempic vs. Semaglutide: 10 Weight Loss Medications Compared for 2025

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

As Super Bowl nears, TV data show GLP-1 game day ads enjoyed a big year

Diabetes and weight management drugs dominated game-day NFL advertising during the regular season, with TV outcomes company ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results